Related Experiment Video
Updated: Nov 20, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Human VAMP3 Suppresses or Negatively Regulates Bax Induced Apoptosis in Yeast
Damilare D Akintade1,2, Bhabatosh Chaudhuri2
1School of Life Sciences, Medical School, University of Nottingham, Nottingham NG7 2UH, UK.
Abstract:
Apoptosis is an essential process that is regulated genetically and could lead to a serious disease condition if not well controlled. Bax is one of the main proapoptotic proteins and actively involved in programmed cell death. It has been suggested that Bax induced apoptosis in yeast could be obstructed by enhancing vesicular membrane trafficking. Plasma membrane proteins and lipid oxidation were reduced by a vesicle-associated membrane protein (VAMP) when expressed in yeast, suggesting its potential role in repairing membranes. Membrane integrity is crucial, as the loss of membrane integrity will result in the leakage of ions from mitochondria, and ultimately cell death due to overproduction of reactive oxygen species (ROS). Expression of Arabidopsis' VAMP has been linked to antiapoptosis activity. Since plant VAMP has been associated with antiapoptotic activities, this study investigates the possible participation of human VAMP3 in blocking human Bax mediated apoptosis. Some novel genes were identified to rescue Bax's proapoptotic effects, in a yeast-based human hippocampal cDNA library screen. VAMP3 (a gene code for proteins involved in protein secretion) gene was chosen for further study to confirm its role in inhibiting apoptosis. VAMP3 was coexpressed with a chromosomally integrated Bax gene expression cassette driven by the GAL1 promoter. The antiapoptotic proteins of the Bcl-2 family (Bcl xL) were known to negate the proapoptotic properties of Bax. However, the new gene (VAMP3) results show that novel antiapoptotic proteins can be identified using a yeast-based assay. The findings presented here show that human VAMP3 protein has antiapoptotic property and could abrogate Bax induced apoptosis (cell death).
Insights
Human VAMP3 protein demonstrates antiapoptotic properties, effectively blocking Bax-induced cell death. This discovery highlights VAMP3 as a potential therapeutic target for preventing apoptosis-related diseases.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Apoptosis, or programmed cell death, is a tightly regulated genetic process crucial for normal development and health.
- Dysregulation of apoptosis can lead to severe diseases.
- Bax is a key proapoptotic protein, and its activity is central to initiating programmed cell death.
Purpose of the Study:
- To investigate the potential antiapoptotic role of human VAMP3.
- To determine if VAMP3 can inhibit apoptosis induced by the proapoptotic protein Bax.
- To identify novel antiapoptotic genes using a yeast-based screening system.
Main Methods:
- A yeast-based screening assay was employed using a human hippocampal cDNA library.
- Novel genes that could rescue Bax-induced proapoptotic effects were identified.
- VAMP3 was coexpressed with a Bax gene expression cassette to assess its antiapoptotic activity.
Main Results:
- Human VAMP3 was identified as a novel gene capable of rescuing Bax-induced apoptosis in yeast.
- VAMP3 demonstrated significant antiapoptotic properties, effectively abrogating cell death mediated by Bax.
- This yeast-based assay successfully identified VAMP3 as a novel antiapoptotic protein.
Conclusions:
- Human VAMP3 protein possesses significant antiapoptotic activity.
- VAMP3 can effectively inhibit or abrogate apoptosis induced by the proapoptotic protein Bax.
- The findings suggest VAMP3 as a potential therapeutic target for diseases associated with excessive apoptosis.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Caspases
Abnormal Proliferation
Apoptosis
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
The Extrinsic Apoptotic Pathway

